GlassScriptPhysician profile
Laura Bradel
NPI 1962963967
$48,382.16
in general payments reported to CMS, 2019-2025
11 companies · $43K in 2025
The $43K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $137 · 2023: $2,447 · 2024: $3,234 · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $33K · Food and Beverage: $8,493 · Travel and Lodging: $7,169 · Education: $82.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $32,500.00 |
| Food and Beverage | $8,492.61 |
| Travel and Lodging | $7,169.20 |
| Education | $82.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,853.04 | 2024-2025 | Assurity, Tacticath, Ensite Precision |
| Boston Scientific Corporation | $14,188.96 | 2024-2025 | Accolade Sr, Farapulse, Avvigo Guidance System |
| Medtronic, INC. | $13,865.29 | 2023-2025 | Micra, Linq II, Mycarelink |
| Boehringer Ingelheim Pharmaceuticals, INC. | $827.78 | 2022-2025 | Jardiance |
| Abiomed | $425.27 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $394.59 | 2023-2024 | Brilinta, Farxiga |
| Pfizer INC. | $378.19 | 2022-2025 | |
| Biosense Webster, INC. | $205.75 | 2025 | Carto 3 |
| Shockwave Medical, INC | $150.02 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $76.13 | 2023-2024 | Camzyos |
| Amgen INC. | $17.14 | 2023 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Bradel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.